SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

New Frontier Health Corp. – ‘15-12B’ on 2/7/22

On:  Monday, 2/7/22, at 6:01am ET   ·   Effective:  2/7/22   ·   Accession #:  1104659-22-12174   ·   File #:  1-38562

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/07/22  New Frontier Health Corp.         15-12B      2/07/22    1:13K                                    Toppan Merrill/FA

Certification of a Termination of Registration of a Class of Securities   —   Form 15   —   § 12(b) – SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 15-12B      Certification of a Termination of Registration of   HTML      9K 
                a Class of Securities                                            


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 15

 

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 001-38562

 

 

 

NEW FRONTIER HEALTH CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

10 Jiuxianqiao Road,
Hengtong Business Park
B7 Building, 1/F
Chaoyang District, 100015,
Beijing, China
Tel: 86-10-59277000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Ordinary Shares, par value US$0.0001 per share

Warrants, each whole warrant exercisable for one Ordinary Share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

 

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

         
Rule 12g-4(a)(1)   x    
Rule 12g-4(a)(2)   ¨    
Rule 12h-3(b)(1)(i)   x    
Rule 12h-3(b)(1)(ii)   ¨    
Rule 15d-6   ¨    

 

Approximate number of holders of record as of the certification or notice date: one

 

 

 C: 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, New Frontier Health Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

Date: February 7, 2022 NEW FRONTIER HEALTH CORPORATION
     
  By:

/s/ Carl Wu 

  Name: Carl Wu
  Title: Director

 

 C: 

 


Dates Referenced Herein

This ‘15-12B’ Filing    Date    Other Filings
Filed on / Effective on:2/7/22None on these Dates
 List all Filings 
Top
Filing Submission 0001104659-22-012174   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 12:54:39.1pm ET